Brian Lee Lawrence
CIK: 0001506228
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 4, 2026IRTC
iRhythm Holdings, Inc.
Sale(S)Direct1K shares at avg. $120.80$122K - Feb 25, 2026IRTC
iRhythm Holdings, Inc.
Award(A)Direct6.7K shares- - May 6, 2025IRTC
iRhythm Technologies, Inc.
Award(A)Direct14.5K shares- - Sep 20, 2024VAPO
VAPOTHERM INC
Disposition(D)Direct22.9K shares- - Sep 20, 2024VAPO
VAPOTHERM INC
Disposition(D)Direct37.3K shares at avg. $2.18$81K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 | IRTC iRhythm Holdings, Inc. | Sale(S) | 1,014 | $120.80 | $122,491 | Direct |
| Feb 25, 2026 | IRTC iRhythm Holdings, Inc. | Award(A) | 6,689 | - | $0 | Direct |
| May 6, 2025 | IRTC iRhythm Technologies, Inc. | Award(A) | 14,479 | - | - | Direct |
| Sep 20, 2024 | VAPO VAPOTHERM INC | Disposition(D) | 22,869 | - | $0 | Direct |
| Sep 20, 2024 | VAPO VAPOTHERM INC | Disposition(D) | 37,319 | $2.18 | $81,355 | Direct |
1-5 of 5 transactions
About Lawrence Brian Lee
Lawrence Brian Lee (SEC CIK 0001506228) files insider reports with the SEC as Chief Technology Officer of iRhythm Holdings, Inc. (IRTC) and SVP & Chief Technology Officer of VAPOTHERM INC (VAPO).
Signal8 holds 6 ownership filings by Lawrence Brian Lee (2 Form 3, 4 Form 4), filed between Sep 24, 2024 and May 5, 2026. Those filings report 5 transactions, from Sep 20, 2024 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lawrence Brian Lee's filings is in SAN FRANCISCO, CA.
Recent filings by Lawrence Brian Lee
Other insiders filing for iRhythm Holdings, Inc. (IRTC)
- Wilson Daniel G., Chief Financial Officer
- Blackford Quentin S., President and CEO
- Murphy Patrick Michael, CBO and CLO
- Patterson Chad, CHIEF COMM & PRODUCT OFFICER
- Shrishrimal Sumi, EVP, Chief Risk Officer
- Turakhia Minang, CHIEF MED/SCI OFCR EVP ADVTECH